BHIC — BioScience Health Innovations Cashflow Statement
0.000.00%
Last trade - 00:00- $46.35m
- $45.66m
- $5.69m
Annual cashflow statement for BioScience Health Innovations, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 August 31st | 2022 November 30th | 2022 August 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 3 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-Q | 10-K | 10-K | 10-K |
| Standards: | USG | — | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.026 | -0.029 | -0.083 | 0.087 | 0.642 |
| Deferred Taxes | |||||
| Non-Cash Items | — | — | -0.009 | — | -0.061 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.004 | 0.001 | 0.006 | -0.064 | -0.407 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.029 | -0.028 | -0.086 | 0.023 | 0.172 |
| Capital Expenditures | — | — | — | -0.026 | -0.057 |
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | — | — | — | -0.026 | -0.057 |
| Financing Cash Flow Items | 0.01 | — | 0 | -0.109 | -0.116 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.011 | 0.04 | 0.1 | 0.646 | -0.116 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.019 | 0.012 | 0.014 | 0.643 | -0.001 |